IJE Advance Access originally published online on December 20, 2005
International Journal of Epidemiology 2006 35(2):337-344; doi:10.1093/ije/dyi274
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
Evidence of bias in estimates of influenza vaccine effectiveness in seniors
1 Center for Health Studies, Group Health Cooperative, Seattle, WA, USA
2 Department of Epidemiology, University of Washington, Seattle, WA, USA
3 Department of Biostatistics, University of Washington, Seattle, WA, USA
4 Department of Medicine, University of Washington, Seattle, WA, USA
* Corresponding author. Center for Health Studies, MPE-16, 1730 Minor Avenue, Seattle, WA 98101, USA. E-mail: jackson.l{at}ghc.org
Background Numerous observational studies have reported that seniors who receive influenza vaccine are at substantially lower risk of death and hospitalization during the influenza season than unvaccinated seniors. These estimates could be influenced by differences in underlying health status between the vaccinated and unvaccinated groups. Since a protective effect of vaccination should be specific to influenza season, evaluation of non-influenza periods could indicate the possible contribution of bias to the estimates observed during influenza season.
Methods We evaluated a cohort of 72 527 persons 65 years of age and older followed during an 8 year period and assessed the risk of death from any cause, or hospitalization for pneumonia or influenza, in relation to influenza vaccination, in periods before, during, and after influenza seasons. Secondary models adjusted for covariates defined primarily by diagnosis codes assigned to medical encounters.
Results The relative risk of death for vaccinated persons compared with unvaccinated persons was 0.39 [95% confidence interval (95% CI), 0.33–0.47] before influenza season, 0.56 (0.52–0.61) during influenza season, and 0.74 (0.67–0.80) after influenza season. The relative risk of pneumonia hospitalization was 0.72 (0.59–0.89) before, 0.82 (0.75–0.89) during, and 0.95 (0.85–1.07) after influenza season. Adjustment for diagnosis code variables resulted in estimates that were further from the null, in all time periods.
Conclusions The reductions in risk before influenza season indicate preferential receipt of vaccine by relatively healthy seniors. Adjustment for diagnosis code variables did not control for this bias. In this study, the magnitude of the bias demonstrated by the associations before the influenza season was sufficient to account entirely for the associations observed during influenza season.
Keywords Influenza/prevention and control, influenza vaccines, cohort studies, bias(epidemiology), confounding factor, epidemiological
Accepted 3 November 2005
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. A. Jackson Benefits of Examining Influenza Vaccine Associations Outside of Influenza Season Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 439 - 440. [Full Text] [PDF]
|
|
|
|
|
|
D. T. Eurich, T. J. Marrie, J. Johnstone, and S. R. Majumdar Mortality Reduction with Influenza Vaccine in Patients with Pneumonia Outside "Flu" Season: Pleiotropic Benefits or Residual Confounding? Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 527 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Belongia, L. A. Coleman, J. G. Donahue, J. C. Nelson, M. L. Jackson, L. A. Jackson, L. Simonsen, C. Viboud, R. J. Taylor, M. M. Braun, et al. Effectiveness of Influenza Vaccination N. Engl. J. Med., December 27, 2007; 357(26): 2728 - 2731. [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. F. Antunes, E. A. Waldman, C. Borrell, and T. M. Paiva Effectiveness of influenza vaccination and its impact on health inequalities Int. J. Epidemiol., December 1, 2007; 36(6): 1319 - 1326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Treanor Influenza -- The Goal of Control N. Engl. J. Med., October 4, 2007; 357(14): 1439 - 1441. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ortqvist, F. Granath, J. Askling, and J. Hedlund Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area Eur. Respir. J., September 1, 2007; 30(3): 414 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Piedra, M. J. Gaglani, C. A. Kozinetz, G. B. Herschler, C. Fewlass, D. Harvey, N. Zimmerman, and W. P. Glezen Trivalent Live Attenuated Intranasal Influenza Vaccine Administered During the 2003 2004 Influenza Type A (H3N2) Outbreak Provided Immediate, Direct, and Indirect Protection in Children Pediatrics, September 1, 2007; 120(3): e553 - e564. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Brookhart, A. R. Patrick, C. Dormuth, J. Avorn, W. Shrank, S. M. Cadarette, and D. H. Solomon Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect Am. J. Epidemiol., August 1, 2007; 166(3): 348 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Jackson, N. S. Weiss, J. C. Nelson, and L. A. Jackson To Rule Out Confounding, Observational Studies of Influenza Vaccine Need to Include Analyses During the "Preinfluenza Period" Arch Intern Med, July 23, 2007; 167(14): 1553 - 1554. [Full Text] [PDF]
|
|
|
|
|
|
L. Simonsen Commentary: Observational studies and the art of accurately measuring influenza vaccine benefits Int. J. Epidemiol., June 22, 2007; (2007) dym084v1. [Full Text] [PDF]
|
|
|
|
|
|
W P. Glezen and L. Simonsen Commentary: Benefits of influenza vaccine in US elderly--new studies raise questions Int. J. Epidemiol., April 1, 2006; 35(2): 352 - 353. [Full Text] [PDF]
|
|